Literature DB >> 25042388

The association of the cribriform pattern with outcome for prostatic adenocarcinomas.

G Kir1, B C Sarbay2, E Gümüş3, C S Topal2.   

Abstract

With the revision of the Gleason system at the 2005 International Society of Urological Pathology Consensus Conference, there was consensus that most cribriform glands should be classified as pattern 4. There is now increased understanding that invasive cribriform carcinoma is a relatively aggressive disease. This study was based on 233 radical prostatectomy (RP) specimens collected at the Department of Pathology, Umraniye Education and Research Hospital, from 2006 to 2013. We assessed the cribriform foci associated with the more definitive patterns 3, 4, and 5 elsewhere on the RP specimens and evaluated the association of the presence of cribriform pattern (CP) with biochemical prostate-specific antigen recurrence (BPR). In Cox regression model, taking into account the Gleason score (GS), pathologic stage, surgical margin (SM) status, presence of a CP, and preoperative prostate-specific antigen (PSA), a positive SM, and the presence of a CP were independent predictors of BPR after RP. We observed BPR more frequently in GS 3+3 cases with a CP than in those without a CP (p=0.008). There was no significant difference in BPR status for cases with GS 3+4, 4+3, 4+5, and 5+4 when the patients were stratified by the presence of a CP. On the basis of these data, we suggest that the classification of CP into Gleason pattern 4 has value in predicting BPR status after RP. However, as many of these modifications are empirical and supported by only a few studies, long-term follow-up studies with clinical endpoints are necessary to validate these recommendations.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cribriform pattern; Gleason pattern; Gleason score; Prostate gland; Prostatic adenocarcinoma

Mesh:

Substances:

Year:  2014        PMID: 25042388     DOI: 10.1016/j.prp.2014.06.002

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  25 in total

1.  [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Authors:  G Kristiansen; L Egevad; M Amin; B Delahunt; J R Srigley; P A Humphrey; J I Epstein
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

2.  Diagnostic performance of 68Ga-PSMA PET/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections.

Authors:  Jie Gao; Chengwei Zhang; Qing Zhang; Yao Fu; Xiaozhi Zhao; Mengxia Chen; Bing Zhang; Danyan Li; Jiong Shi; Feng Wang; Hongqian Guo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-25       Impact factor: 9.236

Review 3.  Grading of Prostate Cancer: Past, Present, and Future.

Authors:  Andres Matoso; Jonathan I Epstein
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

Review 4.  The evolving Gleason grading system.

Authors:  Ni Chen; Qiao Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

Review 5.  Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.

Authors:  Amanda B Hesterberg; Jennifer B Gordetsky; Paula J Hurley
Journal:  Urology       Date:  2021-05-28       Impact factor: 2.633

6.  Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.

Authors:  Patrick Leo; Sacheth Chandramouli; Xavier Farré; Robin Elliott; Andrew Janowczyk; Kaustav Bera; Pingfu Fu; Nafiseh Janaki; Ayah El-Fahmawi; Mohammed Shahait; Jessica Kim; David Lee; Kosj Yamoah; Timothy R Rebbeck; Francesca Khani; Brian D Robinson; Natalie N C Shih; Michael Feldman; Sanjay Gupta; Jesse McKenney; Priti Lal; Anant Madabhushi
Journal:  Eur Urol Focus       Date:  2021-04-30

7.  Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.

Authors:  Daniel M Berney; Luis Beltran; Gabrielle Fisher; Bernard V North; David Greenberg; Henrik Møller; Geraldine Soosay; Peter Scardino; Jack Cuzick
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

Review 8.  On cribriform prostate cancer.

Authors:  Charlotte F Kweldam; Theodorus van der Kwast; Geert J van Leenders
Journal:  Transl Androl Urol       Date:  2018-02

Review 9.  An Updated Review of Cribriform Carcinomas with Emphasis on Histopathological Diagnosis and Prognostic Significance.

Authors:  Giovanni Branca; Antonio Ieni; Valeria Barresi; Giovanni Tuccari; Rosario Alberto Caruso
Journal:  Oncol Rev       Date:  2017-03-10

Review 10.  Grading of prostatic adenocarcinoma: current state and prognostic implications.

Authors:  Jennifer Gordetsky; Jonathan Epstein
Journal:  Diagn Pathol       Date:  2016-03-09       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.